Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.

STOCKHOLM, Oct. 6, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iqlik) is now available in the U.S. as a maintenance dosing regimen for the treatment of Alzheimer’s disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia stage of disease […]

K-Diamonds and KPOP DAO Unite to Launch the World’s First Immersive Web3 Fandom Ecosystem for Global K-Culture

SARASOTA, Fla., Oct. 6, 2025 /PRNewswire/ — Official KPOP LLC (“K-Diamonds”), a Delaware limited liability company, today announced a landmark agreement with KPOP DAO LLC ($KPOP), a Wyoming-registered decentralized autonomous organization, to create the world’s first immersive web3 fandom ecosystem dedicated to K-pop and Korean culture. Continue Reading The Official K-Culture Coin The new ecosystem will […]

AOC Gaming Offers Prime Big Deal Days Savings on High-Performance Gaming Monitors

LOS ANGELES, Oct. 6, 2025 /PRNewswire/ — AOC Gaming today announced limited-time discounts on some of its most popular gaming monitors during Amazon’s Prime Big Deal Days on October 7–8.Known for delivering esports-grade performance, AOC’s deals spotlight premium technologies like QD-OLED, Mini-LED, ultra-fast refresh rates, and portable displays designed for gamers on the go. Highlighted […]

W.T.B. Financial Corporation Announces Share Repurchase Authorization

SPOKANE, Wash., Oct. 6, 2025 /PRNewswire/ — W.T.B. Financial Corporation announced today the amendment of its February 28, 2025, share repurchase plan to increase the authorization from $15 million to $30 million of Class B common stock effective through February 28, 2026. Common share repurchases under the new plan, if any, may be made from […]

Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.

STOCKHOLM, Oct. 6, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iqlik) is now available in the U.S. as a maintenance dosing regimen for the treatment of Alzheimer’s disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia stage of disease […]

Robbins LLP Reminds Cytokinetics, Inc. Investors of the Upcoming Lead Plaintiff Deadline in the Class Action Against CYTK

SAN DIEGO, Oct. 6, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cytokinetics, Inc. (NASDAQ: CYTK) securities between December 27, 2023 and May 6, 2025. Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class […]

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

NEW YORK, Oct. 6, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW). If you currently own shares of Edwards stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=29704 for more information. You may […]